コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 t rejection in selected settings in clinical small bowel transplantation.
2 llected samples taken from 27 patients after small bowel transplantation.
3 D is a fatal and progressive complication of small bowel transplantation.
4 possible because of parenteral nutrition and small bowel transplantation.
5 munosuppression for kidney, liver, lung, and small bowel transplantation.
6 arly posttransplant outcome after orthotopic small bowel transplantation.
7 rtant in mediating enteric dysfunction after small bowel transplantation.
8 Severe skin problems are uncommon after small bowel transplantation.
9 ng tissue damage and improving outcome after small bowel transplantation.
10 red for consideration for combined liver and small bowel transplantation.
11 on the incidence of GVHD and rejection after small bowel transplantation.
12 with inhibition of allograft rejection after small bowel transplantation.
13 dies after allogeneic and semiallogeneic rat small bowel transplantation.
14 tinal failure can then be referred for early small bowel transplantation.
15 volution of acute rejection in this model of small bowel transplantation.
16 gistic effect in preventing allorejection of small bowel transplantation.
17 this review deals with the current status of small-bowel transplantation.
22 s obtained from adult patients who underwent small bowel transplantation at the University of Pittsbu
26 imultaneously induced after fully allogeneic small bowel transplantation, despite rejection being the
27 , a child with this syndrome underwent liver-small bowel transplantation from a 1-of-6 HLA-matched do
28 We analyzed prospective data of 51 primary small bowel transplantations from December 1999 to Augus
32 We hypothesized that, following experimental small bowel transplantation, immunosuppressive therapy i
33 LA4Ig therapy in preventing allorejection of small bowel transplantation in high-responder Lewis rat
34 has a role as a conservative alternative to small bowel transplantation in patients with SBS permane
38 r isolated small bowel or combined liver and small bowel transplantation is approximately 50% at 5 ye
42 Primary abdominal wall closure following small bowel transplantation is frequently impossible due
47 on of phenobarbital treatment and orthotopic small bowel transplantation may be an appropriate therap
51 continuous improvement of immunosuppression, small bowel transplantation (SBT) is plagued by a high i
52 valence of adenoviral infection in pediatric small bowel transplantation (SBT) recipients, examine ri
56 re responsible for the dysmotility following small bowel transplantation (SBTX) are incompletely unde
58 ith biopsy is currently the gold standard of small bowel transplantation (SBTx) monitoring, however i
64 ts with severe cutaneous complications after small bowel transplantation, the work-up, final diagnosi
66 s also prolonged when simultaneous heart and small bowel transplantation was performed in anti-CD4-tr
68 graft-versus-host disease (GvHD) heterotopic small bowel transplantation was performed using DA, PVG,
69 Between August 2008 and October 2014, 29 small bowel transplantations were performed in 28 patien
70 d sepsis can be intimately related following small bowel transplantation when rejection compromises n
71 ent total enterectomy followed by orthotopic small bowel transplantation with or without the colon.